Regulation of amygdalar PKA by β-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning
β-arrestins, key regulators of receptor signaling, are highly expressed in the central nervous system, but their roles in brain physiology are largely unknown. Here we show that β-arrestin-2 is critically involved in the formation of associative fear memory and amygdalar synaptic plasticity. In resp...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 106; no. 51; pp. 21918 - 21923 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
22.12.2009
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | β-arrestins, key regulators of receptor signaling, are highly expressed in the central nervous system, but their roles in brain physiology are largely unknown. Here we show that β-arrestin-2 is critically involved in the formation of associative fear memory and amygdalar synaptic plasticity. In response to fear conditioning, β-arrestin-2 translocates to amygdalar membrane where it interacts with PDE-4, a cAMP-degrading enzyme, to inhibit PKA activation. Arrb2⁻/⁻ mice exhibit impaired conditioned fear memory and long-term potentiation at the lateral amygdalar synapses. Moreover, expression of the β-arrestin-2 in the lateral amygdala of Arrb2⁻/⁻ mice, but not its mutant form that is incapable of binding PDE-4, restores basal PKA activity and rescues conditioned fear memory. Taken together, our data demonstrate that the feedback regulation of amygdalar PKA activation by β-arrestin-2 and PDE-4 complex is critical for the formation of conditioned fear memory. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Author contributions: Y.L., H.L., X.L., and L.M., designed research; Y.L., H.L., X.L., G.B., and Y.T. performed research; Z.W. and P.X. contributed new reagents/analytic tools; Y.L., H.L., X.L., G.B., C.W., B.L. and L.M. analyzed data; and Y.L., H.L., X.L., and L.M. wrote the paper. 1Y.L., H.L., and X.L. contributed equally to this work. Edited by Robert J. Lefkowitz, Duke University Medical Center, Durham, NC, and approved September 11, 2009 |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0906941106 |